Michael Schneider, Luca Paruzzo, Federico Stella, Julia Han Noll, Matthew Ho, Victor Babatunde, Bianca Ho, Pooja Devi, Elise A Chong, Stefan K Barta, Sunita D Nasta, Jakub Svoboda, Jordan Carter, Michael R Cook, Nasheed M Hossain, Colin J Thomas, Vrutti Patel, Vitor B de Souza, Mohannad H Alkhatib, Ziyu Li, Melody Tan, Peter Michener, Puneeth Guruprasad, Antonio Imparato, Alberto Carturan, Patrizia Porazzi, Joseph A Fraietta, Stephen J Schuster, Ivan Maillard, Marco Ruella, Daniel J Landsburg Naïve CD4+ T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy , Nature Communications : 2026
Colin J. Thomas, Ming Jung Koh, Omar Elghawy, et al. Clinical outcomes of mature T- and NK-cell lymphomas in hepatitis B virus positive individuals: results from the PETAL Global Consortium , Leukemia & Lymphoma: 2026
John Sharp, Paolo Strati, Subodh Bhatta, Jennifer J Huang, Colin J Thomas, Omar Elghawy, Daniel Reef, Alexander Micah Gorzewski, John Seng Wang, Geoffrey Shouse, Catherine Reinert, Andinet Teferra, Esteban Toro Velez, Ari Pelcovits, Thomas A Ollila, William Bennett Clark, Victor Yazbeck, Joseph E Maakaron, Manali Kamdar, Lindsey A Fitzgerald, Alexey V Danilov, Reem Karmali, Natalie S Grover, Stefan K Barta, Timothy J Voorhees, Andy I Chen, Mazyar Shadman, Sairah Ahmed, Narendranath Epperla Real-World Outcomes and Toxicities of CAR-T in Relapsed/Refractory Follicular Lymphoma: A Multicenter Cohort Study , Blood Advances: 2026
Daniel J Landsburg, Nancy Musoke, Caren Gentile, Taylor R Brooks, Sunita D Nasta, Stefan K Barta, Jordan S Carter, Elise A Chong, Jakub Svoboda, Stephen J Schuster, Colin J Thomas, Emily B Tomasulo, Michael R Cook, Jennifer J D Morrissette, Paolo F Caimi, Brian T Hill Prognostic impact of TP53 alterations in cases of newly diagnosed large B-cell lymphoma , Leukemia: 2026
Adam J Olszewski, Thomas A Ollila, Dai Chihara, Geoffrey Shouse, Natalie Grover, Reem Karmali, Pallawi Torka, Colin Thomas, Praveen Ramakrishnan Geethakumari, Stefan K Barta, Nancy L Bartlett, Narendranath Epperla Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphoma , Haematologica: 2025
Sharma, M., Myrdal, C., Thomas, C., Chung, J., Barta, S. & Kim, E. A Rare Case of Tender Facial Nodules as a Presenting Sign of Lymphoplasmacytic Lymphoma , JAAD Case Reports, 66: 2025,6:58-61.
Colin J. Thomas & Stefan K. Barta The Promise of Immunotherapies in T-Cell Lymphoma , Clinical Lymphoma, Myeloma & Leukemia, S2152-2650(25): 2025,03399-3.
Nikita K Dave, Veronica Carvajal, Alex C Watts, Jordan S Carter, Michael Cook, Colin Thomas, Donald E Tsai, Stephen J Schuster, James N Gerson, Stefan K Barta, Jakub Svoboda, Elise A Chong, Wei-Ting Hwang, Daniel J Landsburg, Sunita D Nasta Outcomes at a single institution with MTR induction and consolidation in the management of primary CNS lymphoma , Blood Neoplasia, 2(3): 2025,100102.
Narendranath Epperla, Geoffrey Shouse, Natalie S Grover, Pallawi Torka, Kaitlin Annunzio, Marcus Watkins, Andrea Anampa-Guzmán, Beth Christian, Colin Thomas, Stefan K Barta, Praveen Ramakrishnan Geethakumari, Reem Karmali, Nancy L Bartlett, Adam J Olszewski Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - a US multisite study , Experimental Hematology & Oncology , 14(1): 2025
Pallawi Torka, Natalie S. Grover, Timothy J. Voorhees, Reem Karmali, Kaitlin Annunzio, Marcus P. Watkins, Andrea Anampa-Guzmán, Heather Reves, Montreh Tavakkoli, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Nancy L. Bartlett, Geoffrey Shouse, Adam J. Olszewski, Narendranath Epperla Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort Study , Hematological Oncology , 43(3): 2025,e70087.
